The Efficacy of Postoperative Wound Infusion with Bupivacaine for Pain Control after Cesarean Delivery: Randomized Double Blind Clinical Trial
AbstractObjective: This study investigated the efficacy of bupivacaine wound infusion for pain control and opioid sparing effect after cesarean delivery.Materials and methods: We conducted a randomized double blind, placebo controlled clinical trial on 60 parturients undergoing cesarean section at a university hospital in Tehran. Patients were randomized to receive a pump infusion system that was filled with either 0.25% bupivacaine or equal volume of distilled water. A catheter was placed above the fascia and connected to electronic pump for 24 hours. Postoperative analog pain scores and morphine consumption were assessed at 6, 12 and 24 hours. Also time interval to first ambulation, length of hospitalization, complications and patient satisfaction were recorded. Data were analyzed using the SPSS software and P < 0.05 was considered statistically significant. Mann-Whitney u-test, student t-test and chi-square were used. Results: There were no differences in patient demographics and length of hospitalization and patient-generated resting pain scores between the two groups. Pain scores after coughing and leg raise during the first 6 postoperative hours were significantly less in the Bupivacaine group (P<0.001). The total dose of morphine consumption during the 24 hours study period was 2.5 ± 2.5 mg vs. 7.3 ± 2.7 mg for the bupivacaine and control groups, respectively (P<0.001). Compared with the control group, time to first ambulation was shorter in the bupivacaine group (11± 5h vs. 16 ± 4h) (P< 0.01). Conclusion: Bupivacaine wound infusion was a simple and safe technique that provides effective analgesia and reduces morphine requirements after cesarean delivery.
Hillard PA, Berek JS, Novak E. Berek and Novak’s Gynecology. 14 th ed. Philadelphia: Lippincott Williams & Wilkins, 2007:686-88.
David C, Sabiston JR. Sabiston textbook of surgery. 17th ed. Philadelphia: WB. Saunders, 2004: 199-200.
Cucchiara RF, Miller ED, Reves JG, Miller RD. Textbook of Anesthesia. 6th ed. New York: Churchill Livingston, 2005: vol.1: 379-409, 573-598.
Givents VA, Lipscomb GH. . A randomized trial of postoperative wound irrigation with local Anesthetic for pain after cesarean delivery. Am J of obstet Gynecol 2002;186(6): 1188-91.
Fredman B, Shapiro A, Zohar E, Feldman E, Shorer S, Rawal N,et al. The analgesic efficacy of patient-controlled ropivacaine instillation after cesarean delivery. Anesth Analg 2000;91(6): 1436-40.
Fredman B, Zohar E, Tarabykin A, Shapiro A, Mayo A, Klein E, et al. Bupivacaine wound instillation via an electronic patient-controlled analgesia device does not decrease postoperative pain or opioid requirements after major abdominal surgery. Anesth Analg 2001; 92(1): 189-93.
Kristensen BB, Christensen DS, Ostergaard M, Skjelsager K, Nielsen D, Mogensen TS,et al. Lack of postoperative pain relief after hysterectomy using preperitoneally administered bupivacaine. Reg Anesth pain Med 1999; 24(6): 576-80.
Pavy T, Gombling D, kliffer P, Munro A, Merrick PM, Douglas J. Effect of preoperative skin infiltration with bupivacaine on pain after cesarean delivery. Int J Obstet Anesth 1994: 3(4): 199-202.
Ganta R, Samra SK, Furness G. Comparison of the effectiveness of bilateral ilioinguinal nerve block and wound infiltration for postoperative analgesia after Cesarean section. Bri J Anesth 1994: 72(2); 229-30.
Seah YS, Chen C, Ng YT, Chua EC, Tan PP. Ilioinguinal nerve block with 0.375% Marcaine for postoperative pain relief in cesarean section. Ma Zui Xue Za Zhi 1990; 28(3): 307-10.